Resistance training and reduction of treatment side effects in prostate cancer patients.

PURPOSE To examine the effect of progressive resistance training on muscle function, functional performance, balance, body composition, and muscle thickness in men receiving androgen deprivation for prostate cancer. METHODS Ten men aged 59-82 yr on androgen deprivation for localized prostate cancer undertook progressive resistance training for 20 wk at 6- to 12-repetition maximum (RM) for 12 upper- and lower-body exercises in a university exercise rehabilitation clinic. Outcome measures included muscle strength and muscle endurance for the upper and lower body, functional performance (repeated chair rise, usual and fast 6-m walk, 6-m backwards walk, stair climb, and 400-m walk time), and balance by sensory organization test. Body composition was measured by dual-energy x-ray absorptiometry and muscle thickness at four anatomical sites by B-mode ultrasound. Blood samples were assessed for prostate specific antigen (PSA), testosterone, growth hormone (GH), cortisol, and hemoglobin. RESULTS Muscle strength (chest press, 40.5%; seated row, 41.9%; leg press, 96.3%; P < 0.001) and muscle endurance (chest press, 114.9%; leg press, 167.1%; P < 0.001) increased significantly after training. Significant improvement (P < 0.05) occurred in the 6-m usual walk (14.1%), 6-m backwards walk (22.3%), chair rise (26.8%), stair climbing (10.4%), 400-m walk (7.4%), and balance (7.8%). Muscle thickness increased (P < 0.05) by 15.7% at the quadriceps site. Whole-body lean mass was preserved with no change in fat mass. There were no significant changes in PSA, testosterone, GH, cortisol, or hemoglobin. CONCLUSIONS Progressive resistance exercise has beneficial effects on muscle strength, functional performance and balance in older men receiving androgen deprivation for prostate cancer and should be considered to preserve body composition and reduce treatment side effects.

[1]  W. Dahut,et al.  Androgen deprivation therapy for prostate cancer. , 2005, JAMA.

[2]  C. Higano,et al.  Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy , 2004, Cancer.

[3]  R. Newton,et al.  Review of exercise intervention studies in cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Pashos,et al.  Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Abe,et al.  Time course for strength and muscle thickness changes following upper and lower body resistance training in men and women , 2000, European Journal of Applied Physiology.

[6]  Anthony L Zietman,et al.  Changes in body composition during androgen deprivation therapy for prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.

[7]  J. Goodwin,et al.  Risk of fracture after androgen deprivation for prostate cancer. , 2005, The New England journal of medicine.

[8]  M. Scholz,et al.  Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. , 1997, British journal of urology.

[9]  T. DeWeese,et al.  Long‐term effects of androgen deprivation therapy in prostate cancer patients , 2002, Clinical endocrinology.

[10]  R. Parker,et al.  Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. , 2001, The Journal of clinical endocrinology and metabolism.

[11]  L. Lipsitz,et al.  High-intensity strength training in nonagenarians. Effects on skeletal muscle. , 1990, JAMA.

[12]  J. Finkelstein,et al.  Changes in bone mineral density and body composition during initial and long‐term gonadotropin‐releasing hormone agonist treatment for prostate carcinoma , 2005, Cancer.

[13]  K. Courneya,et al.  Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Marcus,et al.  Once‐Weekly Resistance Exercise Improves Muscle Strength and Neuromuscular Performance in Older Adults , 1999, Journal of the American Geriatrics Society.

[15]  H. Wallmann,et al.  Comparison of elderly nonfallers and fallers on performance measures of functional reach, sensory organization, and limits of stability. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  D. Galvão,et al.  Resistance Exercise Dosage in Older Adults: Single‐ Versus Multiset Effects on Physical Performance and Body Composition , 2005, Journal of the American Geriatrics Society.

[17]  J. Goodwin,et al.  Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma , 2005, Cancer.

[18]  J. Cauley,et al.  Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: cross-sectional associations in the Health ABC Study. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  D G Sale,et al.  Neural adaptation to resistance training. , 1988, Medicine and science in sports and exercise.

[20]  Robert U Newton,et al.  American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. , 2011, Medicine and science in sports and exercise.

[21]  P. Kantoff,et al.  Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. , 2001, The New England journal of medicine.

[22]  Matthew R. Smith Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. , 2004, Urology.

[23]  J. Nelson,et al.  Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  K. Courneya Exercise in cancer survivors: an overview of research. , 2003, Medicine and science in sports and exercise.

[25]  R. Newton,et al.  Anabolic responses to resistance training in older men and women: a brief review. , 2005, Journal of aging and physical activity.

[26]  D. Taaffe Sarcopenia--exercise as a treatment strategy. , 2006, Australian family physician.

[27]  A. Dobs,et al.  Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy , 2006, Cancer.

[28]  M. Cooperberg,et al.  The changing face of prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Strength conditioning in older men: skeletal muscle hypertrophy and improved function. , 1988 .